HomeIndustriesFood & BeveragePEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PepsiCo (PEP) rallied on today's earnings, with Alexis Browne Roberts noting a "surprisingly resilient" consumer lifting the numbers. However, she still wouldn't buy the stock even after today's report, giving the case that today's earnings were only "less bad" than it could have been. Dale Smothers still sees the stock as a strong dividend play. One bearish take he gives is America's Ozempic Effect" that will hit PepsiCo's snack profits.

Trading 360

17 Jul 2025

SHARE

ON AIR
5:30 am
The Wrap
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
ON AIR
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor